WSFS Financial's rapid growth and low payout ratio, which indicate a high reinvestment in the business, make it an attractive investment opportunity. The significant growth in both earnings and dividends per share over recent years also adds to its appeal.
The recent insider selling at WSFS Financial could be a matter of concern for investors. Despite some alignment between management and smaller investors, no recent insider transactions could be unsettling.
$ザ・チーズケーキ・ファクトリー(CAKE.US)$initiated at equal-weight by Wells Fargo, announced target price at $33.00. $テキサス・ロードハウス(TXRH.US)$initiated at equal-weight by Wells Fargo, announced targe price at $113.00. $モデルナ(MRNA.US)$was upgraded by UBS from neutral to buy, but decreased target price from $221.00 to $191.00. $ソテラ・ヘルス(SHC.US)$was upgraded by Keybanc from neutral to buy, announced target price at $24.00. $アルファベット クラスC(GOOG.US)$was downg...
WSFSファイナンシャルに関するコメント
コラムUS Top Rating Updates on 6/26: MRNA, GOOG, TSLA, TXRH and More
$テキサス・ロードハウス(TXRH.US)$ initiated at equal-weight by Wells Fargo, announced targe price at $113.00.
$モデルナ(MRNA.US)$ was upgraded by UBS from neutral to buy, but decreased target price from $221.00 to $191.00.
$ソテラ・ヘルス(SHC.US)$ was upgraded by Keybanc from neutral to buy, announced target price at $24.00.
$アルファベット クラスC(GOOG.US)$ was downg...
コラムTop upgrades and downgrades on 4/25
• $アドバンスト・マイクロ・デバイス(AMD)(AMD.US)$ : Raymond James Upgrades to Strong Buy from Outperform - PT $160
• $オートネーション(AN.US)$ : Truist Securities Upgrades to Buy from Hold - PT $140 (from $130)
• $バイオライフ・ソリューションズ(BLFS.US)$ : Oppenheimer Upgrades to Outperform from Perform - PT $28
• $バイオマリン・ファーマシューティカル(BMRN.US)$ : Morgan Stanley Upgrades to Overweight from Equalweight - PT $113 (from $96)
• $ゴーダディ(GDDY.US)$ : Piper Sandler Upgrades to Overweight ...
まだコメントはありません